Asian Spectator


The Times

.

Josh Ferris and Justine Guerard Triumph at the 32nd Laguna Phuket Triathlon, Asia’s Longest-Running Triathlon

Australia’s Ferris and France’s Guerard conquer Phuket’s iconic resort racecourse, as international athletes battle for USD 20,000 in prize money.PHUKET, THAILAND – Media OutR...

Chengdu Hi-tech Zone and Cass Business School Strengthening Co...

CHENGDU, China, July 9, 2019 /PRNewswire-AsiaNet/ -- On June 22 local time in London, Jiaozi Fin-Tech Dreamworks, which is located at Chengdu Hi-tech Zone, signed a cooperation agreement wit...

DDH Graham Selects SS C to Power its Fund Administration Business

WINDSOR, Conn., Oct. 21, 2021 /PRNewswire-AsiaNet/ -- --Australian superannuation funds administrator selects SS&C's Bluedoor SaaS offering to modernize their operations and to enhance t...

2019 World Sensors Summit Unveiled - Zhengzhou Embraces Whole ...

ZHENGZHOU, China, Nov. 12, 2019 /PRNewswire-AsiaNet/ -- Zhengzhou hosted the 2019 World Sensors Summit from November 9-11. Experts from eight countries and regions including China, the US, J...

Why China may want a military base in Indonesia — and why Indonesia is right to reject the idea

A recent report from the US Defence Ministry says China has likely considered a military base in Indonesia, among several other countries in Asia, Africa and the Middle East. It is “v...

FishyHub Singapore Blazes the Trail in Aquarium E-Commerce with Newly Launched Social Platform

SINGAPORE - Media OutReach - 7 February 2022 - As the pioneering marketplace for aquarium e-commerce in Southeast Asia, FishyHub takes one step further with its new social commerce...

Avance Clinical on Top Reasons APAC Biotech Clients Choose Australia for Clinical Trials

Adelaide, AUS, Apr 2, 2020 - (ACN Newswire) - Leading Australian CRO Avance Clinical today detailed the top reasons its APAC biotechs selected Australia for their early phase clinical trial...

The Future of Property Development: Country Garden to Transfor...

FOSHAN, China, July 10, 2019 /PRNewswire-AsiaNet/ -- The new sustainability plan will see the developer extend the use of digital strategies to cover every segment of its business from desig...

Resilience of Saudi Arabia's Credit Ratings Highlight The King...

RIYADH, Saudi Arabia, Oct. 1, 2019 /PRNewswire-AsiaNet/ Over the past week, major Rating Agencies have released updated credit views on Saudi Arabia in response to the attacks of September 1...

SinoMab Granted the Most Popular Newly Listed Company Award

HONG KONG, Jan 10, 2020 - (ACN Newswire) - SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that the Group has won the title of the "Most Popular Newly Listed Company" at the 4th Hong Kong Golden Stocks Awards held in Shenzhen.

image

The 4th Hong Kong Golden Stocks Awards was jointly organized by Zhitongcaijing.com, China's leading information platform focusing on Hong Kong and US stock markets, and 10jka.com.cn. The "Most Popular Newly Listed Company" award aims at recognizing companies had been listed on Hong Kong Stock Exchange since 1 January 2019 with significant recognition from the industry, high participation of investors and excellent performance in capital markets. Being awarded the "Most Popular Newly Listed Company" demonstrates the industry and investors' close attention towards biotech industry and is a great encouragement and motivation for SinoMab's future success. SinoMab, as the first Hong Kong-listed local biopharmaceutical company, possesses several first-in-target and first-in-class drug candidates. As the drug candidate coming the closest to commercialization, the Company's flagship product SM03 is currently in Phase III clinical trial for RA in China and is expected to be marketed in 2021 the soonest. According to the latest statistics, approximately 300 patients have taken the treatment trial. Meanwhile, the Company has proactively carried out long-term development plan. Its Suzhou production base is expected to be put into operation by the end of 2021 to satisfy the commercialized production requirements of drug candidates in the future.

After three months of strict screening, the 4th Hong Kong Golden Stocks Awards attracted over 860 Hong Kong-listed companies to participate, covering emerging industries such as TMT and healthcare. The award is a recognition of SinoMab's R&D strengths, business model and industry influence from the market and investors and will help improving the Company's reputation in the capital market.

About SinoMab BioScience Limited SinoMab BioScience Limited ("SinoMab" or the "Company", stock code: 3681.HK) is dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company's flagship product SM03 is a potential global first-in-target mAb against CD22 for the treatment of rheumatoid arthritis and is currently in Phase III clinical trial for rheumatoid arthritis in China, which has been recognized as one of the significant special projects of Significant New Drugs Development of the Twelfth Five-Year Plan Period and the Thirteenth Five-Year Plan Period. In addition, the Company possesses other potential first-in-target and first-in-class drug candidates, some of which are already in clinical stage, with their indications covering rheumatoid arthritis, systemic lupus erythematosus, non-Hodgkin's lymphoma, asthma, and other diseases with major unmet clinical needs.

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink esim senegalmarsbahisuk casinos not on gamstophttps://www.capitolcitycinema.org/grandpashabet resmi girişStreamEastStreamEastjojobet